Maximize the success of your Translational Neurology plan at Liv Hospital. Learn about long term maintenance, lifestyle engineering, and protecting your brain health.
Send us all your questions or requests, and our expert team will assist you.
Long-Term Care
In translational neurology, patient care does not end when a drug is prescribed; that is when the “Living Lab” phase begins. Long term care involves the continuous collection of data from patients in their daily lives. This Real World Evidence (RWE) is crucial for understanding how treatments work outside the controlled environment of a clinical trial.
Patients become partners in research. By consenting to share their de identified data, they contribute to a global knowledge base. This helps researchers identify rare side effects, understand long term efficacy, and discover which patient subgroups benefit the most from specific interventions.
Long-term care is increasingly managed through digital health platforms. Wearable sensors track gait, sleep, and tremors continuously. This provides a high resolution movie of the patient’s health rather than the snapshot of a clinic visit. Algorithms monitor this data for signs of decline, triggering early interventions.
This technology allows for decentralized clinical trials and care. Patients in rural areas can access cutting edge monitoring without traveling to a major academic center. It democratizes access to specialized neurological care and ensures that geography does not determine health outcomes.
As gene therapies become long term solutions, translational neurology must address complex ethical questions. Long term care involves monitoring for “off target” effects—unintended changes to the DNA that might cause cancer or other issues years later. It also involves the ethics of germline editing (changes passed to children), which is currently prohibited but technically feasible.
The durability of these treatments is a key question. Long term follow up is required to determine if a single dose of gene therapy lasts a lifetime or if re dosing is needed. This requires maintaining registries of treated patients for decades.
The future of long-term care is dynamic and personalized. Treatment plans will be updated in real time based on the patient’s biomarker profile. If a blood test shows inflammation is rising, the anti inflammatory regimen is adjusted immediately. This creates a fluid, responsive care model.
This approach extends to rehabilitation. Using data from sensors, physical therapy can be tailored to the patient’s specific motor deficits. Virtual reality and gaming platforms provide engaging, personalized cognitive and motor training that adapts to the patient’s performance level.
The final phase of translation (T4) focuses on global impact. Translational neurology aims to make advanced diagnostics and treatments scalable and affordable. This involves developing low cost versions of biomarkers (e.g., a paper strip test for blood biomarkers) or simplified delivery systems for gene therapies that do not require specialized surgery.
Ensuring that these medical miracles reach underserved populations is a moral imperative of the field. Translational researchers work with health economists and policy makers to demonstrate the value of these treatments, advocating for coverage and access on a global scale.
Liv Hospital Ulus
Prof. MD. Nebil Yıldız
Neurology
Liv Hospital Ulus
Prof. MD. Nimet Dörtcan
Neurology
Liv Hospital Ulus
Prof. MD. Selda Korkmaz Yakar
Neurology
Liv Hospital Vadistanbul
Prof. MD. Ayhan Öztürk
Neurology
Liv Hospital Vadistanbul
Spec. MD. Hatice Çil
Neurology
Liv Hospital Bahçeşehir
Asst. Prof. MD. Yavuz Bekmezci
Neurology
Liv Hospital Bahçeşehir
MD. Hatice Yelda Yıldız
Neurology
Liv Hospital Bahçeşehir
Prof. MD. Belma Doğan Güngen
Neurology
Liv Hospital Bahçeşehir
Spec. MD. Merve Hilal Dolu
Pediatric Neurology
Liv Hospital Bahçeşehir
Spec. MD. Sevıl Yusıflı
Neurology
Liv Hospital Bahçeşehir
Spec. MD. Yasemin Giray
Neurology
Liv Hospital Topkapı
Assoc. Prof. MD. Figen Yavlal
Neurology
Liv Hospital Topkapı
Spec. MD. Güneş Altıokka Uzun
Neurology
Liv Hospital Ankara
Assoc. Prof. MD. Hatice Balaban
Neurology
Liv Hospital Ankara
Asst. Prof. MD. Özlem Aksoy Özmenek
Neurology
Liv Hospital Ankara
Spec. MD. Filiz Ökten Özyüncü
Neurology
Liv Hospital Gaziantep
Spec. MD. EFTAL GÜRSES SEVİNÇ
Neurology
Liv Hospital Samsun
Prof. MD. Ömer Faruk Aydın
Pediatric Neurology
Liv Hospital Samsun
Spec. MD. Hikmet Dolu
Neurology
Liv Bona Dea Hospital Bakü
MD. AZER QULUZADE
Neurology
Liv Bona Dea Hospital Bakü
Spec. MD. STEVAN TEKIC
Neurology
MD. Dr. Azer Kuluzade
Neurology
Psyc. Selin Ergeçer
Stroke Center
Liv Hospital Ulus + Liv Hospital Vadistanbul
Prof. MD. Gülşen Köse
Pediatric Neurology
Liv Hospital Vadistanbul + Liv Hospital Bahçeşehir
Prof. MD. Yakup Krespi
Neurology
Send us all your questions or requests, and our expert team will assist you.
Real World Evidence is health data collected from everyday life (like medical records, insurance claims, or wearables) rather than from a controlled clinical trial, showing how a drug works in the real world.
Ideally, yes, gene replacement is designed to be a one time, permanent fix, but we are still studying patients to see if the effect lasts for a full lifetime or if it fades.
Being in a registry helps doctors track the long term safety and success of new treatments, ensuring that any rare side effects are caught and that the treatment continues to work as expected.
Off target effects happen when a gene editing tool or drug accidentally interacts with the wrong part of your DNA or the wrong protein, potentially causing unintended side effects.
Remote monitoring allows your doctor to see how you are doing every day without you coming into the clinic, meaning they can catch problems early and adjust your treatment faster.
BlogNeurologyFeb 19, 2026When dealing with spine and brain issues, patients often face a tough choice. They wonder if they should se...
BlogNeurologyDec 01, 2025About 15% of the global population has a neurological disorder. These range from mild cognitive issues to s...
BlogNeurologyDec 01, 2025neurology under internal medicine Did you know that neurological disorders affect millions worldwide? They ...
BlogNeurologyFeb 19, 2026When dealing with spine and brain issues, patients often face a tough choice. They wonder if they should se...
BlogNeurologyDec 01, 2025About 15% of the global population has a neurological disorder. These range from mild cognitive issues to s...
BlogNeurologyDec 01, 2025neurology under internal medicine Did you know that neurological disorders affect millions worldwide? They ...
Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.
Start Chat on WhatsApp or call us at +90 530 510 67 91